Farnesyl Thiosalicylic Acid – 5 mg

Brand:
Cayman
CAS:
162520-00-5
Storage:
-20
UN-No:
Non-Hazardous - /

Association of Ras protein with the inner surface of the plasma membrane is required for Ras signaling activity. Farnesyl thiosalicylic acid (FTS) is an inhibitor of Ras-mediated signaling that functions by dislodging Ras from the cell membrane thereby rendering it susceptible to proteolytic degradation.{15696} FTS inhibits the growth of human Ha-ras-transformed Rat1 fibroblasts with an IC50 value of 7.5 µM.{15698} It does not inhibit Ras farnesylation in vitro and although FTS does inhibit prenylated protein methyltransferase (PPMTase) in cell-free systems with a Ki value of 2.6 µM, it is relatively ineffective at inhibiting methylation in whole cells.{15695} Treatment of chow-fed ApoE-deficient mice with 5 mg/kg FTS three times per week for six weeks reduces early atherosclerotic lesion development by 52% compared to controls.{15694}  

 

Available on backorder

SKU: 10010501 - 5 mg Category:

Description

An inhibitor of Ras-mediated signaling that functions by dislodging Ras from the cell membrane thereby rendering it susceptible to proteolytic degradation; inhibits the growth of human Ha-ras-transformed Rat1 fibroblasts with an IC50 value of 7.5 µM


Formal name: 2-[[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]thio]-benzoic acid

Synonyms:  FTS|Salirasib

Molecular weight: 358.5

CAS: 162520-00-5

Purity: ≥96%

Formulation: A crystalline solid


Product Type|Biochemicals|Lipids|Prenol Lipids||Research Area|Cancer|Cell Signaling|GTPases||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cell Biology|Cell Signaling||Research Area|Lipid Biochemistry|Prenol Lipids